$KMPH Kempharm is dead(ish) until Q1, Q2 of 2022; but could rise before then (17.5 best case...)! The stock, via sales of this ADHD drug they have, will have to prove itself. Q/Q will be closely watched for acceleration (or not...). Anyway! BUY $ARTH... Like a Dogecoin (BUT A REAL COMPANY WITH AN AWESOME PRODUCT; FDA APPROVED FOR ADVANCED WOUND-CARE...)! This stock will be UP TO AT LEAST $1 (maybe $3!) and VERY SOON (by yearend, tops...)!